Table 3.
Comparison of in-hospital outcomes of COVID-19 in patients with DM based on the admission glucose level
| In-hospital outcome† |
Total (N = 169) |
Controlled glucose (N = 27) |
Impaired glucose (N = 30) |
Poor controlled glucose (N = 112) |
P* |
|---|---|---|---|---|---|
| Mortality | 51 (30.2%) | 12 (44.4%) | 7 (23.3%) | 32 (28.6%) | 0.182 |
| Severity | 130 (76.9%) | 16 (59.3%) | 23 (76.7%) | 91 (81.3%) | 0.052 |
| ARDS | 66 (39.1%) | 8 (29.6%) | 13 (43.3%) | 45 (40.2%) | 0.523 |
| Invasive ventilation | 34 (20.1%) | 6 (22.2%) | 5 (16.7%) | 23 (20.5%) | 0.857 |
| ACI | 45 (26.6%) | 2 (7.4%) | 10 (33.3%) | 33 (29.5%) | 0.044 |
| AKI | 36 (21.3%) | 8 (29.6%) | 8 (26.7%) | 20 (17.9%) | 0.297 |
| ALI | 21 (12.4%) | 0 | 0 | 21 (18.8%) | 0.002 |
| Multiorgan damage | 46 (27.2%) | 4 (14.8%) | 8 (26.7%) | 34 (30.4%) | 0.265 |
† Data are presented as number (%)
*Statistically significant P-values are bolded
ACI: acute cardiac injury; AKI: acute kidney injury; ALI: acute liver injury; ARDS: acute respiratory distress syndrome